ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Puxiongzhi Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5001539139. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target. Co-author DOI 10.3389/fimmu.2025.1708441 ↗
Successful treatment of GEMOX regimen combined with nimotuzumab in the pancreatic cancer with wild KRAS and mutant BRCA: a report of two cases. Co-author DOI 10.21037/acr-24-68 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wei Wang · 1 shared paper, 2024 · strength 0.28
- Paper Successful treatment of GEMOX regimen combined with nimotuzumab in the pancreatic cancer with wild KRAS and mutant BRCA… DOI 10.21037/acr-24-68 ↗
Xiangjun Wang · 1 shared paper, 2025 · strength 0.26
- Paper Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 a… DOI 10.3389/fimmu.2025.1708441 ↗
Jian Wang · 1 shared paper, 2025 · strength 0.26
- Paper Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 a… DOI 10.3389/fimmu.2025.1708441 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.